About:

The 2nd Annual Obesity & Cardiometabolic Innovation Forum, organized by Sachs Associates, takes place at the Royal Sonesta New Orleans on June 5, 2026 — strategically positioned the day before ADA's Scientific Sessions open in the same city.

OCIF is a compact, partnering-focused forum convening biotech and pharma executives, investors, and clinical leaders around obesity, diabetes, and cardiovascular-kidney-metabolic disease. The 2026 program includes platform technology panels, corporate presentations, and one-to-one networking, with sessions covering next-generation incretin-based therapies, mitochondrial approaches, and emerging mechanisms beyond GLP-1.

For leaders evaluating opportunities in the cardiometabolic category — one of the most heavily invested and rapidly evolving areas in life sciences — OCIF offers a strategic preview alongside the larger ADA meeting that immediately follows.

🔗 Visit the official event site →

Take your seat at the table. Apply to The Uplyft Collective →